Bionova Scientific, a contract development and manufacturing organisation (CDMO), has announced the installation of a third FlexFactory manufacturing platform from Cytiva as it enters the advanced therapy manufacturing space. The company aims to meet rising demand for genomic medicines while
Bionova Scientific, a boutique biologics CDMO and subsidiary of Asahi Kasei, has announced a licensing agreement with ATUM to incorporate its proprietary Leap-In Transposase gene delivery system and miCHO cell line development technologies into Bionova’s manufacturing platform. The Leap-In Transposase
Bionova Scientific has announced a partnership with Bionique Testing Laboratories, appointing the contract research organisation (CRO) as its preferred provider for mycoplasma testing services. The collaboration aims to support the efficient manufacturing of biologics, reinforcing both companies’ roles within the bioprocess division
Bionova Scientific, an Asahi Kasei company and boutique biologics contract development and manufacturing organisation (CDMO), has opened a new facility in Fremont, California. The 55,000 sq. ft. process development and pilot plant is designed to advance early-stage biologics assets to
Bionova Scientific, an Asahi Kasei Group company and a full-service biologics contract manufacturing organization (CDMO), has announced its intention to expand into plasmid DNA (pDNA) production. The initiative will be centered around a new development and manufacturing facility located in
